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A new series of β-hydroxytriazoles were synthesized and evaluated as Mycobacterium tuberculosis 
inhibitors. Our strategy implied the synthesis of alkyne precursors through a Barbier reaction 
between benzaldehydes and propargyl bromide followed by click chemistry to afford substituted β-
hydroxyl benzyltriazoles. These compounds are also key intermediates either for oxidation reactions 
leading to α,β-diketotriazoles or for elimination reactions affording styryl triazoles. Evaluation of 
all new compounds for in vitro antitubercular activity against Mycobacterium tuberculosis H37Rv 
resulted in compounds with MIC up to 7 µM.   
________________________________________________________________________________ 
Introduction 
 Tuberculosis (TB) is a highly contagious 
bacterial disease. It remains with malaria and 
AIDS, one of the biggest causes of death 
worldwide. For illustration, around 2 million 
deaths occur each year as a result of this disease 
[1]. Tuberculosis is caused by Mycobacterium 
tuberculosis (Mtb), and current 
chemotherapeutic treatments are based on the 
use of antibiotics, the most important are: 
isoniazid (INH), rifampicin, pyrazinamide, 
ethambutol and streptomycin. Their efficiency 
was severely compromised by the emergence of 
multi- and extensively drug-resistant 
tuberculosis [2]. In the last 10 years, the 
research on M. tuberculosis has progressed with 
the genome unrevealed, facilitating the 
discovery of new targets [3]. Nevertheless, there 
is an urgent need for new anti-TB drug 
candidates.  
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 Azole derivatives showed high potency 
as antimycobacterial drugs [4]. Among them, 
econazole was very promising to replace the 
most potent frontline antitubercular drugs 
namely rifampicin and isoniazid [5]. Recently, 
different groups reported the synthesis of 1H-
1,2,3-triazoles derived from econazole as 
antitubercular agents [6-7]. Among them, nine 
hydroxyl-triazoles were evaluated and 
particularly one compound bearing a n-butyl 
substituent at position 4 of the triazole (Figure 
1, middle) showed the best activity with a MIC 
of 25 µM. Our group also reported the synthesis 
of triazole derivatives and their evaluation as 
M.tb inhibitors [8-11]. Among them, several 
compounds showed interesting MIC values 
when tested against M.tb and M.tb antibiotic-
resistant strains. 
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Figure 1. Left: Econazole. Middle: Hydroxyl-triazoles 
tested on Mycobacterium tuberculosis H37Rv strain (Kim 
et al., 2012); Right: Our work: β-hydroxytriazole and 
related scaffolds with modifications on indicated sites (R, 
R1, R2 and R3) 
 In continuation of our research on the 
synthesis of biologically active heterocycles 
against tuberculosis [8,10-12], we wish to report 
the synthesis and the evaluation of a wide range 
of β-hydroxytriazole derivatives against M.tb 
H37Rv (Figure 1, right). This work also 
described the antitubercular activities of a new 
series of  α,β-diketotriazoles and styryl triazoles 
synthesized conveniently from the 
corresponding β-hydroxytriazoles. 
 
Results and discussion 
Chemistry  
 As shown in Scheme 1, β-
hydroxytriazoles are synthesized in two steps 
from commercially available benzaldehydes 
according to a two-step procedure. α,β-
Diketotriazoles and styryltriazoles could be 
obtained accordingly by oxidation or 
elimination of the β-hydroxytriazoles.  
 It has to be noted that this method is 
more convenient for obtaining α,β-
diketotriazoles, the number of commercially 
available benzaldehydes being significantly 
higher than that of phenyl acetic acid derivatives 
[9]. 
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Scheme 1 Strategy for the synthesis of the desired β-
hydroxytriazoles, precursors of α,β-ketotriazoles and 
styryl derivatives. 
 
 Adopting this synthetic strategy, the first 
step was the Barbier condensation of propargyl 
bromide with different commercial 
benzaldehydes in the presence of zinc in a 
solution of THF/NH4Cl (2/1) (Scheme 2). 
However, the alkyne product was always 
accompanied, even after flash chromatography 
purification, by a side product identified as the 
corresponding ketene (<5% after purification). 
The triazole intermediates were then readily 
available by copper-catalyzed alkyne-azide 
cycloaddition reaction (CuAAC) [13-14]. The 
results are shown in Table 1. The yields 
remained good regardless of the different alkyl 
or benzyl groups bearing various electron-
donating or electron-withdrawing substituents.  
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Scheme 2 General synthesis of the triazole alcohols. 
 In the case of the synthesis of 
compounds 2r and 2s, the corresponding azides 
were obtained from commercially available Z 
and E mixture of geranyl bromide (20% Z 
isomer by 1H NMR). Then “click” products 2r 
and 2s were isolated with both stereochemistries 
Z and E, separable by flash chromatography. 
 The oxidation of the alcohol derivatives 
was also investigated to afford α,β-
diketotriazoles in one step. A quick check in the 
literature showed that the conversion of 1,2-
diphenylethanol derivatives to the 
corresponding diketone compound was not fully 
exploited. Indeed, a few examples showed the 
formation of benzil analogues through this 
pathway. In 2011, Urgoitia et al. used two 
palladacycles in the presence of molecular 
oxygen in PEG-400, a sustainable reaction 
media [15]. With a different substrate, diketone 
product could be obtained also when either 
MnO2 or Pd(OAc)2 was employed as the 
oxidant [16]. In a different way, 4,7-di-tert-
butyl-acenaphthen-1-ol was oxidized to 
diketone in the presence of SeO2 (13.5 equiv.) 
in dioxane under reflux [17]. 
 We used alcohol 2a as a model 
compound to examine the feasibility of a fully 
complete oxidation reaction to obtain α,β-
diketotriazoles. The results are described in 
Table 2.  
While oxidants like PCC, MnO2, Döering 
reagent, CuI/TBHP afforded the desired product 
only in low or very low yields, 2-iodoxybenzoic 
acid (IBX) was found to allow the complete 
conversion of the starting alcohol compound 
within 2 h (Table 2). The α,β-diketo-derivative 
was isolated in 64% yield (table 2, entry 5).  
Table 1 Synthesis of triazoles. 
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 A higher amount of IBX did not permit 
to increase the yield of the reaction (entry 7), 
while, changing the solvent for DMSO led to a 
much lower yield (28%) (entry 6). The 
generation of IBX in situ with 2-iodobenzoic 
acid (2IBA, 0.6 eq) and oxone (2.4 eq) afforded 
the oxidation product in 65% (entry 9).  
 Finally, decreasing the quantity of 
reactants or lowering the temperature is 
detrimental to the yield, even after 20 h (entries 
8, 10). With this method in hand (entry 9), 
several β-alcohols were oxidized allowing the 
obtention of the corresponding α,β-
diketotriazoles in good yields as shown in Table 
1. However, in the presence of alkoxy 
substituents on the aromatic moiety, the reaction 
led to the desired diketo compounds 3c-3e and 
3g in poor yields. Furthermore, the product 3f 
bearing 3,4-dimethoxy substituents was not 
observed. 
Table 2 Screening of reaction conditions for the oxidation 
to α,β-diketotriazole. 
OH
N
NN oxidation
O
N
NN
O
2a 3a
solvent
 
Entry Oxidant Solvent Conditions Yield 
(%) 
1 PCC (2 eq) CH2Cl2 RT, 4 h 23 
2 MnO2 (6 eq) CH3CN Reflux, 7 h 18 
3 Doering CH3CN Reflux, 3 h 6 
4 CuI (0.1 eq), 
TBHP (2 * 4 eq) 
CH3CN Reflux, 20 h 12 
5 IBX (1.5 eq) CH3CN 70°C, 20 h 64 
6 IBX (1.5 eq) DMSO 70°C, 20 h 28 
7 IBX (3 eq)  CH3CN 70°C, 20 h 60 
8 2IBA (0.3 eq) + 
oxone (1.2 eq) 
CH3CN/H2O 
(2/1) 
70°C, 7 h 30 
9 2IBA (0.6 eq) + 
oxone (2.4 eq) 
CH3CN/H2O 
(2/1) 
70°C, 3 h 65 
10 2IBA (0.6 eq) + 
oxone (2.4 eq) 
CH3CN/H2O 
(2/1) 
50°C, 20 h 53 
 Styryl triazole derivatives are scaffolds 
possessing various biological properties. For 
example, they were evaluated as potential 
ligands for angiogenic growth factors FGF-1, 
FGF-2 and VEGF [18] but also as candidates 
for β-amyloid (Aβ) plaque imaging [19]. The 
synthesis of styryl derivatives 4a-e was 
performed in two steps from the corresponding 
alcohol as shown in Table 3. Formation of the 
bromide derivative combining triphenyl 
phosphine and carbon tetrabromide with 2, 
followed by an elimination step using DBU at 
room temperature afforded 4a-4e in good yields.  
Table 3 Synthesis of styryl derivatives. 
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 The assignment of E stereochemistry for 
all styryl compounds was based on the J CH=CH 
coupling constant of 16-17 Hz. 
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Biology 
Bacterial growth experiments against M. 
tuberculosis H37Rv strain 
 The minimal inhibitory concentration 
(MIC) values (μg/mL and μM) of all of the 
synthesized compounds and one standard 
antitubercular drug (Isoniazid) were determined 
in triplicate and are shown in Table 4.  
 Looking first to the results of triazole 
alcohol systems we evaluated the influence of 
the substitution on the aromatic ring of the 
benzyl hydroxyl frame. Among the alkyl or 
alkoxy substituents the best activity was 
observed for the compound bearing a p-propoxy 
one (2d) with a MIC of 14 µM. Halogenation of 
the aromatic ring leads to compounds with 
activities depending on the positioning of the 
halogen. Thus when only the positions 4 (2h, 2t, 
2u) or 2 (2i) or 2,6 (2j) of the aromatic ring are 
halogenated, the activity is weak whatever the 
halogen. In fact, compounds bearing a 2,4 
dichloro substitution on the aromatic ring 
presented the best inhibitory activities. This 
indicates the strong influence of the 2,4-dichloro 
substitution on the MIC activities of all 
compounds tested, the best inhibitor in this 
series showing a MIC of 7.2 µM (2k).  
 Upon examining the different systems 
attached to the nitrogen atom of the triazole 
frame, we can notice that any substitution on the 
benzylic frame is detrimental to the activity. 
This is also the case for compound 2q bearing a 
lipophilic C-8 chain. Finally, the best result was 
obtained for compound 2s, bearing the Z-
geranyl chain. It is noteworthy to point out that 
the E-geranyl analogue is much less active. All 
these results indicate the fine tuning and the 
great susceptibility upon activity for any 
substitution on the nitrogen atom of the triazole 
frame. Considering the diketo compounds, we 
can observe that substitution pattern is not as 
crucial as before.  
Table 4 Compounds tested as inhibitory agents of M. 
tuberculosis growth. 
Cpds MIC 
(µg/ml)/(µM) 
Cpds MIC 
(µg/ml)/(µM) 
2a >40/>135.4 3a 40/130.1 
2b 10/32.3 3b 40/124.5 
2c >40/>122.9 3c 5/15.6 
2d 5/14.1 3d 40/109.4 
2e >40/>122.9 3e 
 
40/118.5 
2f 40/112.5 3f 
 
--- 
2g 40/111.7 3g 
 
20/53.8 
2h >40/>121.3 3h 
 
40/117.0 
2i 20/60.64 3i 
 
20/60.64 
2j 40/109.8 3j 
 
20/53.1 
2k 2.5/7.2 3k 
 
5/13.9 
2l >20/>52.9 3l 
 
--- 
2m 20/49 3m 4/9.5a 
2n 20/52.3 3n --- 
2o 
 
20/51 3o 5/13.4a 
2p 20/55.2 3p 
 
--- 
2q 
 
20/54 3q 32/80.7a 
2r 5/12.7 3r 
 
--- 
2s >20/>50.7 3s 
 
--- 
2t 40/127.6 3t 
 
40/123.0 
2u 20/53.4 3u 
 
40/103.5 
isoniazid 0.05/0.4   
a. Reference [11] 
 
 In fact, the benzylic moiety can afford 
substituents on the aromatic ring such as 
methoxy, 2,4-dichloro, but also substituents on 
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the N-1 position of the triazole such as 
substituted benzylic, phenylethyl and still 
maintain good inhibitory activity. In that 
respect, the diketo compounds can afford more 
flexibility concerning the substitution on both 
sides of the triazole ring than the corresponding 
triazolo alcohol derivatives.  
Table 5 Activities of the styryl derivatives. 
Cpds MIC 
     (µg/ml)/(µM) 
4a 40/112.2 
4b 10/28.9 
4c >40/>125.2 
4d >40/>118.5 
4e >40/>130.1 
 
 The styryl triazole derivatives were also 
evaluated. The results showed that they are not 
good inhibitors of M. tuberculosis excepted for 
compound 4b with a MIC of 29 µM, bearing the 
n-propoxy substituent on the aromatic ring. It is 
also noteworthy to point out that the 2,4-
dichloro compound is not active while the 
corresponding hydroxyl and diketo analogue 
possess good MIC values.   
Cytotoxicities of some selected compounds 
 Finally, the cytotoxicity of three 
different compounds was evaluated on two 
human cell lines, the colon cancer cell line 
HCT116 and the fibroblast cell line GM637 
(Table 6). The two alcohols 2d and 2k are not 
cytotoxic when tested at 100 µM. For 
comparison with 2k, the diketo and the styryl 
derivatives 3k and 4b have no cytotoxicity 
below 50 µM. 
Table 6 Cytotoxicities of compounds 2d, 2k and 3k. 
Cpds IC50 (µM) 
HCT116 strain 
IC50 (µM) 
GM637H strain 
2d >100 >100 
2k >100 >100 
3k >50 >50 
4b 50 < IC50 < 100 50 < IC50 < 100 
 
Conclusions 
 In summary, the synthesis of a new 
series of β-hydroxytriazole, α,β-diketotriazole 
and styryl derivatives and their evaluation as 
antitubercular inhibitors are reported. 
Additionally, a convenient method to afford α,β-
diketotriazoles from β-hydroxytriazoles was 
developed in which the key step was the double 
oxidation of the benzylic moieties using IBX 
generated in situ as oxidant. The antimicrobial 
activities against M. tuberculosis H37Rv of all 
compounds showed selective trends on the 
substitution patterns of the triazole ring for the 
benzylic compounds and to a much lesser extent 
to the diketo ones. Several derivatives displayed 
promising MIC values in the range of 7-15 μM 
with best one (2k) at 7.2 μM. 
Experimental section/Computational details 
Material 
All chemicals were obtained from Aldrich or 
Acros Organics and used without further 
purification. Nuclear magnetic resonance 
spectra were recorded on a Bruker AC 300 
spectrometer (1H and 13C NMR). Mass 
spectrometry (MS) data were obtained on a 
ThermoQuest TSQ 7000 spectrometer, high-
resolution mass spectra (HRMS) were 
performed on a ThermoFinnigan MAT 95 XL 
spectrometer using electrospray ionization 
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(ESI) methods. IR spectra were recorded on a 
Perkin Elmer 1725. 
Synthesis and characterizations 
 
Synthesis of 1-phenylbut-3-yn-1-ol derivatives:  
Zinc (9.4 mmol, 2 eq) was added to a solution 
of benzaldehyde (4.7 mmol, 1 eq) and propargyl 
bromide (9.4 mmol, 2 eq) in a mixture (2/1) of 
THF and a solution of saturated aqueous NH4Cl. 
The reaction was stirred vigorously at room 
temperature for 5 h. Then the reaction mixture 
was diluted with AcOEt and washed with H2O. 
The solvent was dried with MgSO4, filtered and 
evaporated under reduced pressure. The desired 
product was purified on a silica gel column by 
flash chromatography. These compounds are 
known for most of them and the spectroscopic 
data match those reported (1-phenylbut-3-yn-1-
ol (1a, 60%) [20], 1-(4-methylphenyl)but-3-yn-
1-ol (1b, 66%) [21], 1-(4-methoxyphenyl)but-3-
yn-1-ol (1c, 48%) [20], 1-(3-
methoxyphenyl)but-3-yn-1-ol (1d, 60%) [20], 
1-(3,4-dimethoxyphenyl)but-3-yn-1-ol (1f, 
41%) [22], 1-(4-chloropheny)but-3-yn-1-ol (1h, 
75%) [20], 1-(2-chloropheny)but-3-yn-1-ol (1i, 
24%) [20], 1-(2,6-dichlorophenyl)but-3-yn-1-ol 
(1j, 74%) [23], 1-(2,4-dichlorophenyl)but-3-yn-
1-ol (1k, 88%) [20], 1-(4-fluorophenyl)but-3-
yn-1-ol (1t, 23%) [21], 1-(4-bromophenyl)but-
3-yn-1-ol (1u, 78%) [23]. The synthesized 
products were used as such for the next reaction 
(presence of α-allenol <5-10% by 1H NMR).  
 
1-(4-Propoxyphenyl)but-3-yn-1-ol (1e). 
Yield: 57%. 1H NMR (CDCl3) δ 7.26 (d, J = 8.4 
Hz, 2H); 6.86 (d, J = 8.7 Hz, 2H); 4.78 (t, J = 
6.3 Hz, 1H); 3.90 (t, J = 6.6 Hz, 2H); 2.62 (m, 
2H); 2.04 (t, J = 2.6 Hz, 1H); 1.79 (m, 2H); 1.03 
(t, J = 7.4 Hz, 3H).  
1-(3-Chloro-4-methoxyphenyl)but-3-yn-1-ol 
(1g).  
Yield: 61%. 1H NMR (CDCl3) δ 7.33 (d, J = 2.2 
Hz, 1H); 7.16 (dd, J = 8.5 Hz, 2.1 Hz, 1H); 6.84 
(d, J = 8.5 Hz, 1H); 4.71 (t, J = 6.3 Hz, 1H); 
3.83 (s, 3H); 2.99 (br s, 1H); 2.53 (dd, J = 6.4 
Hz, 2.6 Hz, 2H); 2.04 (t, J = 2.6 Hz, 1H). 
Procedure for the synthesis of triazole 
derivatives: 
CuSO4 (0.2 equiv) and sodium ascorbate (0.4 
equiv) were added to a solution of alkyne (0.7 
mmol, 1 eq ) and azide (0.84 mmol, 1.2 eq) in 
tBuOH/H2O (1/1) at room temperature. Then 
the reaction mixture was diluted with AcOEt 
and washed with H2O. The solvent was dried 
with MgSO4, filtered and evaporated under 
reduced pressure. The desired product was 
purified on a silica gel column by flash 
chromatography.  
2-(1-Benzyl-1H-1,2,3-triazol-4-yl)-1-
phenylethanol (2a).  
White powder. Yield 70%. M.p. 104 °C. 
M.p.:102 °C. IR (neat, ν/cm-1) 3238; 3119; 
1551; 1454; 1425; 1H NMR (CDCl3)  δ 7.12-
7.31 (m, 11H); 5.38 (d, J = 14.9 Hz, 1H); 5.32 
(d, J = 14.9 Hz, 1H); 4.96 (t, J = 6.3 Hz, 1H); 
3.95 (br s, 1H); 3.03 (d, J = 6.3 Hz, 2H); 13C 
NMR (CDCl3) δ 145.0; 143.5; 134.6; 128.8; 
128.4; 128.1; 127.7; 127.2; 125.6; 122.1; 72.8; 
53.7; 35.3; HRMS: (DCI/CH4, m/z) calc. for 
C17H18N3O :280.1450. Found: 280.1444. 
2-(1-Benzyl-1H-1,2,3-triazol-4-yl)-1-p-
tolylethanol (2b). 
 
White powder. Yield 62%. M.p.: 105 °C. IR 
(neat, ν/cm-1) 3150; 2921; 1606; 1558; 1497; 
1452; 1H NMR (CDCl3) δ 7.34 (m, 3H); 7.19 
(m, 5H); 7.09 (d, J = 7.9 Hz, 2H); 5.47 (d, J = 
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14.9 Hz, 1H); 5.41 (d, J = 14.9 Hz, 1H); 4.97 (t, 
J = 6.3 Hz, 1H); 3.39 (br s, 1H); 3.05 (d, J = 6.3 
Hz, 2H); 2.31 (s, 3H); 13C NMR (CDCl3) δ 
145.2; 140.6; 137.0; 134.6; 128.93; 128.90; 
128.5; 127.8; 125.6; 122.0; 72.9; 53.9; 35.4; 
21.0; HRMS: (DCI/CH4, m/z) calc. for 
C18H20N3O: 294.1606. Found: 294.1609. 
2-(1-Benzyl-1H-1,2,3-triazol-4-yl)-1-(4-
methoxyphenyl)ethanol (2c). 
White powder. Yield 64%. M.p.: 92 °C. IR 
(neat, ν/cm-1) 3126; 1610; 1584; 1510; 1248; 1H 
NMR (CDCl3) δ 7.32 (m, 3H); 7.22 (d, J = 8.7 
Hz, 2H); 7.17 (m, 3H); 6.81 (d, J = 8.6 Hz, 2H); 
5.43 (d, J = 8.6 Hz, 2H); 5.46 (d, J = 15.1 Hz, 
1H); 5.4 (d, J = 15.1 Hz, 1H); 4.96 (br s, 1H); 
3.76 (s, 3H); 3.56 (br s, 1H); 3.03 (m, 2H); 13C 
NMR (CDCl3) δ 158.8; 135.8 (br.); 134.7; 
128.9; 128.5; 127.8; 126.9; 113.6; 72.7; 55.1; 
53.9; 35.4; HRMS: (DCI/CH4, m/z) calc. for 
C18H20N3O2: 310.1556. Found: 310.1556. 
2-(1-Benzyl-1H-1,2,3-triazol-4-yl)-1-(4-
propoxyphenyl)ethanol (2d). 
White powder. Yield 40%. M.p.: 99 °C. IR 
(neat, ν/cm-1): 3215; 3215; 2919; 1609; 1509; 
1242; 1H NMR (CDCl3) δ 7.35 (m, 3H); 7.23 
(m, 5H); 6.83 (d, J = 8.7 Hz, 2H); 5.48 (s, 2H); 
4.99 (t, J = 6.1 Hz, 1H); 3.90 (t, J = 6.6 Hz, 
2H); 3.06 (d, J = 6.2 Hz, 2H); 1.80 (m, 2H+1H); 
1.03 (t, J = 7.4 Hz, 3H); 13C NMR (CDCl3) δ 
158.5; 145.3; 135.5; 134.7; 129.0; 128.6; 127.9; 
126.9; 122.0; 114.3; 72.8; 69.4; 54.0; 35.4; 22.5; 
10.5; HRMS: (DCI/CH4, m/z) calc. for 
C20H24N3O2: 338.1869. Found: 338.1879. 
2-(1-Benzyl-1H-1,2,3-triazol-4-yl)-1-(3-
methoxyphenyl)ethanol (2e). 
White powder. Yield 71%. M.p. 73 °C. IR (neat, 
ν/cm-1) 3343; 3124; 1611; 15861493; 1432; 
1266; 1H NMR (CDCl3) δ 7.32 (m, 3H); 7.19 
(m, 4H); 6.89 (d, J = 2.1 Hz, 1H); 6.86 (d, J = 
7.6 Hz, 1H); 6.76 (dd, J = 8.1 Hz, 2.7 Hz, 1H); 
5.44 (d, J = 15.0 Hz, 1H); 5.38 (d, J = 15.0 Hz, 
1H); 4.96 (t, J = 6.3 Hz, 1H); 3.73 (s, 3H); 3.38 
(br s, 1H); 3.04 (m, 2H); 13C NMR (CDCl3) 
δ 159.5; 145.3; 145.0; 134.6; 129.2; 128.9; 
128.5; 127.8; 122.1; 118.0; 113.0; 11.0; 72.9; 
55.0; 53.8; 35.3; HRMS: (DCI/CH4, m/z) calc. 
for C18H20N3O2: 310.1556. Found: 310.1549. 
1-(1-Benzyl-1H-1,2,3-triazol-4-yl)-2-(3,4-
dimethoxyphenyl)ethanol (2f). 
Brown gum. Yield 75%. IR (neat, ν/cm-1) 2935; 
2835; 1593; 1516; 1455; 1263; 1138; 1H NMR 
(CDCl3) δ 7.35 (m, 3H); 7.21 (m, 3H); 6.91 (s, 
1H); 6.84 (d, J = 8.3 Hz, 1H); 6.77 (d, J = 8.2 
Hz, 1H); 5.49 (d, J = 15.0 Hz, 1H); 5.44 (d, J = 
15.0 Hz, 1H); 4.98 (br s, 1H); 3.84 (s, 3H); 3.83 
(s, 3H); 3.06 (m, 1H); 13C NMR (CDCl3) δ 
148.9; 148.3; 136.8; 136.3; 136.2; 134.6; 129.0; 
128.7; 127.9; 117.9; 110.8; 108.9; 73.0; 55.84; 
55.77; 54.0; 35.5; HRMS: (DCI/CH4, m/z) calc. 
for C19H21N3O3: 339.1583. Found: 339.1586.  
2-(1-Benzyl-1H-1,2,3-triazol-4-yl)-1-(3-chloro-
4-methoxyphenyl)ethanol (2g).  
White powder. Yield 70%. M.p.: 118 °C. IR 
(neat, ν/cm-1) 3218; 1605; 1551; 1498; 1457; 
1260; 1H NMR (CDCl3) δ 7.09-7.35 (m, 8H); 
6.78 (d, J = 8.3 Hz, 2H); 5.42 (d, J = 15.6 Hz, 
1H); 5.37 (d, J = 15.6 Hz, 1H); 4.91 (br s, 1H); 
3.81 (s, 3H); 2.98 (br s, 2H); 13C NMR (CDCl3) 
δ 153.9; 137.2; 137.1; 136.9; 134.5; 128.9; 
128.5; 127.7; 127.6; 125.1; 121.9; 111.6; 72.0; 
56.0; 53.9; 35.2; HRMS: (DCI/CH4, m/z) calc. 
for C18H19N3O2Cl: 344.1166. Found: 344.1173. 
2-(1-Benzyl-1H-1,2,3-triazol-4-yl)-1-(4-
chlorophenyl)ethanol (2h).  
White powder. Yield 71%. M.p.: 115 °C. IR 
(neat, ν/cm-1) 3207; 2929; 1552; 1456; 1435; 1H 
NMR (CDCl3) δ 7.33 (m, 3H); 7.19 (m, 4H); 
7.15 (m, 3H); 5.43 (d, J = 14.9 Hz, 1H); 5.37 (d, 
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J = 14.9 Hz, 1H); 4.97 (t, J = 6.1 Hz, 1H); 4.02 
(br s, 1H); 3.00 (d, J = 6.2 Hz, 2H); 13C NMR 
(CDCl3) δ 144.7; 142.1; 134.5; 132.8; 128.9; 
128.6; 128.2; 127.8; 127.1; 72.2; 53.9; 35.2; 
HRMS: (DCI/CH4, m/z) calc. for C17H17N3OCl: 
314.1060. Found: 314.1045.  
1-(1-Benzyl-1H-1,2,3-triazol-4-yl)-2-(2-
chlorophenyl)ethanol (2i).  
White powder. Yield 76%. M.p. 136 °C. IR 
(neat, ν/cm-1) 3207; 2928; 1552; 1455; 1H NMR 
(CDCl3) δ 7.53 (dd, J = 7.5 Hz, 1.9 Hz, 1H); 
7.34 (m, 3H); 7.28 (dd, J = 7.6 Hz, 1.6 Hz, 1H); 
7.13-7.24 (m, 5H); 5.46 (s, 2H); 5.38 (dd, J = 
8.2 Hz, 3.1 Hz, 1H); 3.68 (br s, 1H); 3.20 (dd, J 
= 15.1 Hz, 3.2 Hz, 1H); 2.96 (dd, J = 15.1 Hz, 
8.3 Hz, 1H); 13C NMR (CDCl3) δ 145.0; 140.8; 
134.5; 131.4; 129.1; 129.0; 128.6; 128.3; 127.9; 
127.2; 126.9; 121.9; 69.7; 54.0; 33.2; HRMS: 
(DCI/CH4, m/z) calc. for C17H17N3OCl: 
314.1060. Found: 314.1049. 
2-(1-Benzyl-1H-1,2,3-triazol-4-yl)-1-(2,6-
dichlorophenyl)ethanol (2j). 
White powder. Yield 53%. M.p.: 110 °C. IR 
(neat, ν/cm-1) 3217; 2923; 1560; 1430; 1H NMR 
(CDCl3) δ 7.34 (m, 3H); 7.20-7.26 (5H); 7.09 
(dd, J = 8.7 Hz, 7.2 Hz, 1H); 5.70 (br s, 1H); 
5.50 (d, J = 14.9 Hz, 1H); 5.43 (d, J = 14.9 Hz, 
1H); 3.54 (dd, J = 14.9 Hz, 9.1 Hz, 1H); 3.50 
(br s, 1H); 3.21 (dd, J = 14.8 Hz, 5.2 Hz, 1H); 
13C NMR (CDCl3) δ 136.6; 134.7; 134.3; 129.3; 
129.02; 128.96; 128.5; 127.9; 71.1; 54.0; 53.4; 
31.4; HRMS: (DCI/CH4, m/z) calc. for 
C17H16N3OCl2: 348.0670. Found: 348.0678. 
2-(1-Benzyl-1H-1,2,3-triazol-4-yl)-1-(2,4-
dichlorophenyl)ethanol (2k). 
 White powder. Yield %. M.p.: 132 °C. IR (neat, 
ν/cm-1) 3172; 2929; 1604; 1588; 1497; 1461; 1H 
NMR (CDCl3) δ 7.45 (d, J = 8.4 Hz, 1H); 7.36 
(m, 3H); 7.29 (d, J = 2.1 Hz, 1H); 7.15-7.25 (m, 
4H); 5.48 (s, 2H); 5.34 (m, 1H); 4.23 (br s, 1H); 
3.17 (dd, J = 15.0 Hz, 2.3 Hz, 1H); 2.93 (dd, J = 
15 Hz, 7.9 Hz, 1H); 13C NMR (CDCl3) δ  139.4; 
134.5; 133.3; 131.9; 129.1; 128.9; 128.8; 128.3; 
128.0; 127.2; 69.4; 54.1; 33.0; HRMS: 
(DCI/CH4, m/z) calc. for C17H16N3OCl2: 
348.0670. Found: 348.0663.  
1-(2,4-Dichlorophenyl)-2-(1-(3-methoxybenzyl)-
1H-1,2,3-triazol-4-yl)ethanol (2l). 
Colorless oil. Yield 58%. IR (neat, ν/cm-1) 
3214; 2923; 1601; 1493; 1467; 1325; 1261. 1H 
NMR (CDCl3) δ  7.43 (d, J = 8.4 Hz, 1H); 7.28 
(m, 2H); 7.20 (s, 1H); 7.16 (dd, J = 8.4 Hz, 2.1 
Hz, 1H); 6.88 (dd, J = 8.3 Hz, 2.4 Hz, 1H); 6.77 
(m, 2H); 5.42 (s, 2H); 5.33 (dd, J = 8.0 Hz, 3.3 
Hz, 1H); 3.77 (s, 3H); 3.16 (dd, J = 15.1 Hz, 
3.4Hz, 1H); 2.92 (dd, J = 15.1 Hz, 8.0 Hz, 1H) ; 
13C NMR (CDCl3) δ  160.0; 144.6; 139.4; 
135.9; 133.3; 131.9; 130.1; 128.8; 128.3; 127.2; 
121.9; 120.1; 113.9; 113.7; 69.3; 55.2; 54.0; 
33.1; HRMS: (DCI/CH4, m/z) calc. for 
C18H18N3O2Cl2: 378.0776. Found: 378.0777. 
1-(2,4-Dichlorophenyl)-2-(1-(3,5-
dimethoxybenzyl)-1H-1,2,3-triazol-4-yl)ethanol 
(2m).  
Colorless oil. Yield 68%. IR (neat, ν/cm-1) 
3219; 2926; 2839; 1597; 1463; 1354; 1208. 1H 
NMR (CDCl3) δ 7.46 (d, J = 8.4 Hz, 1H); 7.30 
(d, J = 2.1 Hz, 1H); 7.21 (s, 1H); 7.19 (dd, J = 
8.5 Hz, 2.1 Hz, 1H); 6.43 (t, J = 2.2 Hz, 1H); 
6.36 (d, J = 2.2 Hz, 2H); 5.40 (s, 2H); 5.35 (dd, 
J = 8.0 Hz, 3.3 Hz, 1H); 3.76 (s, 6H); 3.18 (dd, 
J = 15.1 Hz, 3.2 Hz, 1H); 2.92 (dd, J = 15.1 Hz, 
7.9 Hz, 1H); 13C NMR (CDCl3) δ  161.3; 144.7; 
139.4; 136.5; 133.4; 132.0; 128.9; 128.3; 127.2; 
121.9; 106.1; 100.2; 69.4; 55.4; 54.2; 33.0; 
HRMS: (DCI/CH4, m/z) calc. for 
C19H20N3O3Cl2: 408.0882. Found: 408.0880. 
2-(1-(3-Chlorobenzyl)-1H-1,2,3-triazol-4-yl)-1-
(2,4-dichlorophenyl)ethanol (2n). 
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Colorless oil. Yield 55%. IR (neat, ν/cm-1) 
2927; 1580; 1561; 1466; 14321380; 1319; 1223. 
1H NMR (CDCl3) δ  7.43 (d, J = 8.4 Hz, 1H); 
7.30 (m, 3H); 7.23 (s, 1H); 7.19 (m, 2H); 7.08 
(dt, J = 6.8 Hz, 1.8Hz, 1H); 5.43 (s, 2H); 5.34 
(dd, J = 7.9 Hz, 3.5 Hz, 1H); 3.57 (brs, 1H); 
3.18 (dd, J = 15.1 Hz, 3.4 Hz, 1H); 2.95 (dd, J = 
15.2 Hz, 7.8 Hz, 1H); 13C NMR (CDCl3) δ  
144.8; 139.4; 136.4; 134.9; 133.4; 131.9; 130.3; 
128.93; 128.87; 128.3; 127.9; 127.2; 126.0; 
69.2; 53.3; 33.1; HRMS: (DCI/CH4, m/z) calc. 
for C17H15N3OCl3: 382.0281. Found: 382.0271. 
1-(2,4-Dichlorophenyl)-2-(1-phenethyl-1H-
1,2,3-triazol-4-yl)ethanol (2o). 
Colorless oil. Yield 80%. IR (neat, ν/cm-1) 
3030; 1587; 1559; 1464; 1382; 1215. 1H NMR 
(CDCl3) δ  7.49 (d, J = 8.4 Hz, 1H); 7.20-733 
(m, 5H); 7.08 (m, 3H); 5.30 (dd, J = 8.2 Hz, 3.0 
Hz, 1H); 4.55 (t, J = 7.2 Hz, 2H); 3.39 (brs, 
1H); 3.18 (t, J = 7.1 Hz, 2H); 3.14 (dd, J = 15.1 
Hz, 3.1 Hz, 1H); 2.88 (dd, J = 15.1 Hz, 8.3 Hz, 
1H); 13C NMR (CDCl3) δ 144.1; 139.5; 136.9; 
133.4; 132.0; 128.9; 128.8; 128.6; 128.3; 127.2; 
127.1; 122.3; 69.5; 51.6; 36.6; 33.0; 30.9; 
HRMS: (DCI/CH4, m/z) calc. for 
C18H18N3OCl2: 362.0827. Found: 392.0826. 
1-(2,4-Dichlorophenyl)-2-(1-(2-
methoxyphenethyl)-1H-1,2,3-triazol-4-
yl)ethanol (2p).  
Colorless oil. Yield 86%. IR (neat, ν/cm-1) 
2937; 2836; 1589; 1496; 1464; 1239. 1H NMR 
(CDCl3) δ 7.51 (d, J = 8.4 Hz, 1H); 7.33 (d, J = 
2.1 Hz, 1H); 7.23 (m, 2H); 7.07 (s, 1H); 6.80-
6.93 (m, 3H); 5.29 (dd, J = 8.4 Hz, 3.0 Hz, 1H); 
4.55 (t, J = 7.1 Hz, 2H); 3.83 (s, 3H); 3.16 (t, J 
= 7.2 Hz, 2H); 3.15 (dd, J = 15.1 Hz, 3.1 Hz, 
1H); 2.86 (dd, J = 15.1 Hz, 8.4 Hz, 1H); 13C 
NMR (CDCl3) δ  157.4; 144.0; 139.5; 133.3; 
132.0; 130.6; 128.9; 128.5; 128.3; 127.2; 125.1; 
122.1; 120.6; 110.3; 69.5; 55.2; 49.9; 33.0; 32.0; 
HRMS: (DCI/CH4, m/z) calc. for 
C19H20N3O2Cl2: 392.0933. Found: 392.0932. 
1-(2,4-Dichlorophenyl)-2-(1-octyl-1H-1,2,3-
triazol-4-yl)ethanol (2q).  
Colorless oil. Yield 65%. IR (neat, ν/cm-1) 
2954; 2926; 2856; 1589; 1561; 1467; 1380; 
1219. 1H NMR (CDCl3) δ  7.51 (d, J = 8.4 Hz, 
1H); 7.32 (d, J = 2.1 Hz, 1H); 7.28 (s, 1H); 7.22 
(dd, J = 8.4 Hz, 2.1 Hz, 1H); 5.35 (dd, J = 8.2 
Hz, 3.0 Hz, 1H); 4.30 (t, J = 7.2 Hz, 2H); 3.20 
(dd, J = 15.1 Hz, 3.1 Hz, 1H); 2.93 (dd, J = 15.1 
Hz, 8.2 Hz, 1H); 1.86 (m, 2H); 1.26 (m, 10H); 
0.87 (t, J = 6.7 Hz, 3H); 13C NMR (CDCl3) 
δ  144.3; 139.6; 133.4; 132.0; 128.9; 128.4; 
127.2; 121.7; 69.5; 50.3; 33.0; 31.7; 30.2; 29.0; 
28.9; 26.4; 22.6; 14.0; HRMS: (DCI/CH4, m/z) 
calc. for C18H26N3OCl2: 370.1453. Found: 
370.1446. 
(E)-1-(2,4-dichlorophenyl)-2-(1-(3,7-
dimethylocta-2,6-dienyl)-1H-1,2,3-triazol-4-
yl)ethanol (2r).  
Colorless oil. Yield 27%. IR (neat, ν/cm-1) 
2921; 2850; 1589; 1562; 1467; 1382; 1221. 1H 
NMR (CDCl3) δ 7.54 (d, J = 8.4 Hz, 1H); 7.33 
(d, J = 2.1 Hz, 1H); 7.22-7.26 (m, 2H); 5.37 (m, 
2H); 5.05 (m, 1H); 4.93 (d, J = 7.3 Hz, 2H); 
3.20 (dd, J = 15.2 Hz, 3.0 Hz, 1H); 2.91 (dd, J = 
15.1 Hz, 8.2 Hz, 1H); 2.11 (m, 4H); 1.76 (s, 
3H); 1.67 (s, 3H); 1.59 (s, 3H); 13C NMR 
(CDCl3) δ 144.4; 143.5; 139.5; 133.4; 132.2; 
132.0; 128.9; 128.4; 127.3; 123.4; 121.2; 116.8; 
69.5; 47.9; 39.3; 33.1; 26.0; 25.7; 17.7; 16.4; 
HRMS: (DCI/CH4, m/z) calc. for 
C20H26N3OCl2: 394.1453. Found: 394.1438. 
(Z)-1-(2,4-dichlorophenyl)-2-(1-(3,7-
dimethylocta-2,6-dienyl)-1H-1,2,3-triazol-4-
yl)ethanol (2s).  
Colorless oil. Yield 17%. IR (neat, ν/cm-1). 
2923; 2851; 1590; 1562; 1467; 1380; 1220. 1H 
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NMR (CDCl3) δ  7.53 (d, J = 8.4 Hz, 1H); 7.33 
(m, 1H); 7.22-7.27 (m, 2H); 5.36 (m, 2H); 5.11 
(m, 1H); 4.91 (d, J = 6.9 Hz, 2H); 3.22 (d, J = 
15.1 Hz, 1H); 2.94 (m, 1H); 2.21 (m, 4H); 1.84 
(s, 3H); 1.71 (s, 3H); 1.64 (s, 3H); 13C NMR 
(CDCl3) δ  144.4; 143.2; 139.6; 133.4; 132.7; 
132.0; 128.9; 128.4; 127.3; 123.1; 121.2; 117.7; 
69.5; 47.7; 33.1; 32.0; 26.2; 25.7; 23.4; 17.7; 
HRMS: (DCI/CH4, m/z) calc. for 
C20H26N3OCl2: 394.1453. Found: 394.1447. 
1-(1-Benzyl-1H-1,2,3-triazol-4-yl)-2-(4-
fluorophenyl)ethanol (2t).  
White powder. Yield 72%. M.p.: 100 °C. IR 
(neat, ν/cm-1) 3364; 1603; 1557; 1508; 1216; 1H 
NMR (CDCl3) δ  7.30 (m, 3H); 7.15 (m, 5H); 
6.88 (t, J = 8.6 Hz, 2H); 5.39 (d, J = 15.1 Hz, 
1H); 5.33 (d, J = 15.1 Hz, 1H); 4.95 (m, 1H); 
4.35 (br s, 1H); 2.98 (s, 3H); 13C NMR (CDCl3) 
δ  161.7 (1JC-F = 245.0 Hz); 139.4; 134.5; 128.8; 
128.4; 127.6; 127.3; 127.2; 114.8 (2JC-F = 21.3 
Hz); 72.1; 53.7; 35.3; HRMS: (DCI/CH4, m/z) 
calc. for C17H17N3OF: 298.1356. Found: 
298.1360. 
2-(1-Benzyl-1H-1,2,3-triazol-4-yl)-1-(4-
bromophenyl)ethanol (2u).  
White powder. Yield 78%. M.p.: 116 °C. IR 
(neat, ν/cm-1) 3422; 1591; 155; 1487; 1454; 1H 
NMR (CDCl3) δ 7.34 (m, 5H); 7.15 (m, 5H); 
5.44 (d, J = 14.9 Hz, 1H); 5.38 (d, J = 514.9 Hz, 
1H); 4.96 (t, J = 6.2 Hz, 1H); 4.03 (br s, 1H); 
3.00 (d, J = 6.2 Hz, 2H); 13C NMR (CDCl3) δ  
144.6; 142.6; 134.5; 131.2; 129.0; 128.6; 127.8; 
127.4; 122.0; 121.0; 72.3; 53.9; 35.2; HRMS: 
(DCI/CH4, m/z) calc. for C17H17N3OBr: 
358.0555. Found: 358.0558.  
Procedure for the synthesis of α,β-
diketotriazole derivatives.  
2-Iodobenzoic acid (0.6 equiv), oxone (2.4 
equiv) were added to a solution of alcohol 
(mmol, 1 equiv) in 3 mL of AcCN/H2O (2/1) at 
room temperature. The reaction mixture was 
warmed to reflux and was stirred under air for 
20 h. Then the solvent was evaporated under 
reduced pressure and the residue was dissolved 
in AcOEt. The organic layer was washed with 
water (3 x 20 mL), dried over MgSO4 and 
concentrated under reduced pressure. The 
residue was purified by flash chromatography.  
The compounds 3a, 3c and 3k are known for 
most of them and the spectroscopic data match 
those reported.[9] 
1-(1-Benzyl-1H-1,2,3-triazol-4-yl)-2-p-
tolylethane-1,2-dione (3b).  
White powder. Yield 78%. M.p.: 137 °C. IR 
(neat, ν/cm-1) 3123; 2920; 1677; 1661; 1604; 
1518; 1245; 1H NMR (CDCl3) δ  8.21 (s, 
1H); 7.89 (d, J = 8.3 Hz, 2H); 7.38 (m, 3H); 
7.26-7.33 (m, 4H); 5.59 (s, 2H); 2.41 (s, 3H); 
13C NMR (CDCl3) δ 191.6; 185.7; 146.2; 144.4; 
133.3; 130.3; 129.8; 129.6; 129.3; 129.2; 128.4; 
128.3; 54.5; 21.9; HRMS: (DCI/CH4, m/z) calc. 
for C18H16N3O2: 306.1243. Found: 306.1244. 
1-(1-Benzyl-1H-1,2,3-triazol-4-yl)-2-(4-
propoxyphenyl)ethane-1,2-dione (3d). 
White powder. Yield %. M.p. 98 °C. IR (neat, 
ν/cm-1): 3100; 2943; 1675; 1660; 1595; 1567; 
1268; 1H NMR (CDCl3) δ 8.17 (s, 1H); 8.00 (d, 
J = 9.0 Hz, 2H); 7.30-7.42 (m, 5H); 6.95 (d, J = 
9.0 Hz, 2H); 5.60 (s, 2H); 4.00 (t, J = 6.6 Hz, 
2H); 1.83 (m, 2H); 1.04 (t, J = 7.4 Hz, 3H); 13C 
NMR (CDCl3) δ  190.3; 185.6; 164.7; 144.5; 
133.3; 132.8; 129.4; 129.3; 128.4; 125.1; 114.7; 
69.9; 54.5; 22.3; 10.4; HRMS: (DCI/CH4, m/z) 
calc. for C20H20N3O3: 350.1505. Found: 
315.1496. 
2-(1-Benzyl-1H-1,2,3-triazol-4-yl)-1-(3-
methoxyphenyl)ethane-1,2-dione (3e).  
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White powder. Yield 26%. M.p.: 120 °C. IR 
(neat, ν/cm-1) 3101; 2939; 1670; 1597; 1517; 
1461; 1281; 1H NMR (CDCl3) δ  8.19 (s, 1H); 
7.55 (m, 2H); 7.30-7.42 (m, 6H); 7.19 (ddd, J = 
8.2 Hz, 2.5 Hz, 1.1 Hz, 1H); 5.60 (m, 2H); 3.84 
(s, 3H); 13C NMR (CDCl3) δ  191.9; 185.6; 
159.9; 144.5; 133.5; 133.2; 129.9; 129.4; 129.3; 
128.4; 128.1; 123.4; 122.0; 113.1; 55.5; 54.6; 
HRMS: (DCI/CH4, m/z) calc. for C18H16N3O3: 
322.1192. Found: 322.1184. 
1-(1-Benzyl-1H-1,2,3-triazol-4-yl)-2-(3-chloro-
4-methoxyphenyl)ethane-1,2-dione (3g).  
White powder. Yield 49%. M.p.: 139 °C. IR 
(neat, ν/cm-1) 3122; 2926; 1679; 1668; 1593; 
1278; 1H NMR (CDCl3) δ 8.22 (s, 1H); 8.05 (d, 
J = 2.1 Hz, 1H); 7.93 (dd, J = 8.7 Hz, 2.1 Hz, 
1H); 7.29-7.40 (m, 5H); 6.98 (d, J = 8.7 Hz, 
1H); 5.60 (s, 2H); 3.97 (s, 3H); 13C NMR 
(CDCl3) δ  189.3; 184.9; 160.2; 144.2; 133.3; 
132.0; 131.2; 129.3; 129.2; 128.5; 128.4; 125.8; 
123.5; 111.6; 56.5; 54.5; HRMS: (DCI/CH4, 
m/z) calc. for C18H15N3O3Cl: 356.0802. Found: 
356.0801. 
1-(1-Benzyl-1H-1,2,3-triazol-4-yl)-2-(4-
chlorophenyl)ethane-1,2-dione (3h).  
 
White powder. Yield 61%. M.p.: 123 °C. IR 
(neat, ν/cm-1) 3119; 2923; 1691; 1674; 1587; 
1531; 1H NMR (CDCl3) δ 8.24 (s, 1H); 7.95 (d, 
J = 8.6 Hz, 2H); 7.46 (d, J = 8.6 Hz, 2H); 7.39 
(m, 3H); 7.31 (m, 2H); 5.60 (s, 2H); 13C NMR 
(CDCl3) δ  190.5; 184.9; 144.2; 141.6; 133.2; 
131.5; 130.6; 129.34; 129.28; 128.42; 128.38; 
54.5; HRMS: (DCI/CH4, m/z) calc. for 
C17H13N3O2Cl: 326.0696. Found: 326.0703. 
1-(1-Benzyl-1H-1,2,3-triazol-4-yl)-2-(2-
chlorophenyl)ethane-1,2-dione (3i).  
White powder. Yield 82%. M.p.: 125 °C. IR 
(neat, ν/cm-1) 3148; 2922; 1677; 1566; 1H NMR 
(CDCl3) δ 8.24 (s, 1H); 7.83 (dd, J = 8.2 Hz, 2.0 
Hz, 1H); 7.52 (m, 1H); 7.30-7.45 (m, 7H); 5.61 
(m, 2H); 13C NMR (CDCl3) δ 192.0; 183.5; 
143.7; 134.5; 134.0; 133.3; 133.1; 132.0; 130.4; 
129.3; 129.2; 128.4; 127.2; 54.5; HRMS: 
(DCI/CH4, m/z) calc. for C17H13N3O2Cl: 
326.0710. Found: 326.0710. 
1-(1-Benzyl-1H-1,2,3-triazol-4-yl)-2-(2,6-
dichlorophenyl)ethane-1,2-dione (3j).  
White powder. Yield 83%. M.p.: 116 °C. IR 
(neat, ν/cm-1) 3121; 1712; 1690; 1677; 1577; 
1430; 1H NMR (CDCl3) δ 8.50 (s, 1H); 7.33-
7.42 (m, 8H); 5.65 (s, 2H); 13C NMR (CDCl3) δ  
189.7; 178.0; 141.6; 134.6; 133.4; 132.6; 132.2; 
130.0; 129.3; 129.2; 128.3; 128.1; 54.5; HRMS: 
(DCI/CH4, m/z) calc. for C17H12N3O2Cl2: 
360.0307. Found: 360.0316. 
1-(1-Benzyl-1H-1,2,3-triazol-4-yl)-2-(4-
fluorophenyl)ethane-1,2-dione (3t).  
White powder. Yield %. M.p.: 86 °C. IR (neat, 
ν/cm-1) 3111; 1671; 1595; 1520; 1240; 1H NMR 
(CDCl3) δ 8.24 (s, 1H); 8.06 (d, J = 8.6 Hz, 1H); 
8.04 (d, J = 8.7 Hz, 1H); 7.33 (m, 5H); 7.16 (t, J 
= 8.5 Hz, 2H); 5.60 (s, 2H); 13C NMR (CDCl3) 
δ  190.1; 185.1; 166.8 (1JC-F = 258.4 Hz); 144.2; 
133.3; 133.1; 133.0; 129.33; 129.26; 128.7 (3JC-
F = 2.9 Hz); 128.4; 116.2 (2JC-F = 22.2 Hz); 54.5; 
HRMS: (DCI/CH4, m/z) calc. for C17H13N3O2F: 
310.0992. Found: 310.0998. 
2-(1-Benzyl-1H-1,2,3-triazol-4-yl)-1-(4-
bromophenyl)ethane-1,2-dione (3u).  
Yellow powder. M.p.: 130 °C. Yield %. IR 
(neat, ν/cm-1) 3131; 2953; 1690; 1671; 1578; 
1515; 1245; 1H NMR (CDCl3) δ 8.24 (s, 1H) ; 
7.86 (d, J = 8.7 Hz, 2H); 7.62 (d, J = 8.7 Hz, 
2H); 7.29-7.40 (m, 5H); 5.60 (s, 2H); 13C NMR 
(CDCl3) δ  190.7; 184.8; 144.1; 133.2; 131.4; 
131.0; 130.5; 129.3; 129.2; 128.4; 128.3; 54.5; 
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HRMS: (DCI/CH4, m/z) calc. for 
C17H13N3O2Br: 370.0191. Found: 370.0209. 
General procedure for elimination reaction.  
A mixture of PPh3 (1.4 equiv.), CBr4 (1.25 
equiv.) and alcohol (0.3 mmol, 1equiv.) in 
anhydrous dichloromethane (4 mL) was stirred 
at room temperature. The progress of the 
reaction was followed by TLC. The solvent was 
removed under vacuum and the product was 
purified by silica gel chromatography using a 
mixture of petroleum ether/ethyl acetate.  
The product was used directly for the next step. 
DBU (1.5 equiv.) was added in dichloromethane 
at 4°C and the mixture was stirred at room 
temperature for 1h. When the reaction was 
complete by TLC, the mixture was washed with 
HCl (1N), brine and concentrated under reduced 
pressure.  The residue was purified by silica gel 
column chromatography to afford the 
corresponding styryl derivatives.   
(E)-1-Benzyl-4-(4-methoxystyryl)-1H-1,2,3-
triazole (4a).  
White powder. Yield 37%. M.p.: 183 °C. IR 
(neat, ν/cm-1) 3107; 3037; 2835; 1606; 1509; 
1435; 1260; 1H NMR (CDCl3) δ 7.49 (s, 1H); 
7.42 (m, 5H); 7.30 (m, 2H); 7.22 (d, J = 16.5 
Hz, 1H); 6.92 (d, J = 16.4 Hz, 1H); 6.88 (m, 
2H); 5.53 (s, 2H); 3.81 (s, 3H); 13C NMR 
(CDCl3) δ  159.5; 147.0; 134.7; 130.3; 129.5; 
129.1; 128.7; 128.0; 127.7; 119.8; 114.6; 114.1; 
55.3; 54.1; HRMS: (DCI/CH4, m/z) calc. for 
C18H18N3O: 292.1450. Found: 292.1461. 
 
(E)-1-Benzyl-4-(4-propoxystyryl)-1H-1,2,3-
triazole (4b).  
White powder. Yield 82%. M.p.: 163°C. IR 
(neat, ν/cm-1): 3091; 2965; 2878; 1605; 1509; 
1253; 1239; 1H NMR (CDCl3) δ  7.45 (s, 1H); 
7.37 (m, 5H); 7.29 (m, 2H); 7.21 (d, J = 16.5 
Hz, 1H); 6.91 (d, J = 16.5 Hz, 1H); 6.87 (d, J = 
8.8 Hz, 2H); 5.53 (s, 2H); 3.93 (t, J = 6.6 Hz, 
2H); 1.80 (m, 2H); 1.03 (t, J = 7.4 Hz, 3H); 13C 
NMR (CDCl3) δ  159.1; 147.0; 134.7; 130.4; 
129.3; 129.1; 128.7; 128.0; 127.7; 119.7; 114.7; 
114.4; 69.5; 54.1; 22.5; 10.5; HRMS: 
(DCI/CH4, m/z) calc. for C20H22N3O: 320.1763. 
Found: 320.1775. 
(E)-1-Benzyl-4-(3,4-dimethoxystyryl)-1H-1,2,3-
triazole (4c).  
Yellow powder. Yield 25%. M.p.: 194 °C. IR 
(neat, ν/cm-1): 3104; 2965; 1599; 1581; 1512; 
1264; 1H NMR (CDCl3) δ 7.46 (s, 1H); 7.37 (m, 
3H); 7.28 (m, 2H); 7.19 (d, J = 16.4 Hz, 1H); 
7.02 (d, J = 1.9 Hz, 1H); 6.99 (dd, J = 8.3 Hz, J 
= 1.9 Hz, 1H); 6.93 (d, J = 16.4 Hz, 1H); 6.83 
(d, J = 8.2 Hz, 1H); 5.52 (s, 2H); 3.90 (s, 3H); 
3.88 (s, 3H); 13C NMR (CDCl3) δ  149.10; 
149.07; 146.8; 134.6; 130.4; 129.8; 129.1; 
128.7; 128.0; 119.9; 119.8; 114.9; 111.1; 108.5; 
55.9; 55.8; 54.1; HRMS: (DCI/CH4, m/z) calc. 
for C19H20N3O2: 322.1556. Found: 322.1566. 
(E)-1-Benzyl-4-(2,4-dichlorostyryl)-1H-1,2,3-
triazole (4d).  
White powder. Yield 52%. M.p.: 109°C. IR 
(neat, ν/cm-1): 3099; 2922; 2852; 1554; 1472; 
1389; 1H NMR (CDCl3) δ 7.57 (s, 1H); 7.55 (d, 
J = 7.1 Hz, 1H); 7.51 (d, J = 15.9 Hz, 1H); 7.38 
(m, 3H); 7.31 (m, 2H); 7.22 (dd, J = 8.5 Hz, J = 
2.1 Hz, 1H); 7.05 (d, J = 16.5 Hz, 1H); 5.55 (s, 
2H); 13C NMR (CDCl3) δ  146.2; 134.5; 133.83; 
133.77; 129.6; 129.2; 128.8; 128.1; 127.3; 
127.1; 125.5; 120.6; 120.0; 54.2; HRMS: 
(DCI/CH4, m/z) calc. for C17H14N3Cl2: 
330.0565. Found: 330.0574. 
(E)-1-benzyl-4-(4-bromostyryl)-1H-1,2,3-
triazole (4e).  
White powder. Yield 73%. M.p.: 180 °C. IR 
(neat, ν/cm-1) 3090; 3046; 1605; 1487; 1457; 
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1223; 1H NMR (CDCl3) δ 7.26-7.48 (m, 10H); 
7.21 (d, J = 16.5 Hz, 1H); 7.02 (d, J = 16.4 Hz, 
1H); 5.53 (s, 2H); 13C NMR (CDCl3) δ  146.2; 
135.6; 134.5; 131.8; 129.3; 129.1; 128.8; 128.0; 
127.9; 121.6; 120.4; 117.3; 54.1; HRMS: 
(DCI/CH4, m/z) calc. for C17H15N3Br: 340.0449. 
Found: 340.0461. 
Growth conditions and minimum inhibitory 
concentration (MIC) determination in M. 
tuberculosis 
H37Rv was used as the reference strain. The 
strains were grown at 37 °C in Middlebrook 
7H9 broth (Difco), supplemented with 0.05% 
Tween 80, or on solid Middlebrook 7H11 
medium (Difco) supplemented with oleic acid-
albumin-dextrose-catalase (OADC). MICs for 
the new compounds were determined by means 
of the micro-broth dilution method. Dilutions of 
M. tuberculosis wild-type (about 105–106 
cfu/ml) were streaked onto 7H11 solid medium 
containing a range of drug concentrations (0.25 
µg/mL to 40 µg/mL). Plates were incubated at 
37 °C for about 21 days and the growth was 
visually evaluated. The lowest drug dilution at 
which visible growth failed to occur was taken 
as the MIC value. Results were expressed as the 
average of at least three independent 
determinations. 
Cytotoxicities. 
Human colon cancer cell line HCT116 (ATCC) 
and human fibroblasts (GM637 cell line) were 
cultured in DMEM supplemented with 10% 
fetal calf serum. For cytotoxicity evaluation, 
3000 cells were seeded per well in 96-wells 
plates and, 24 h later, were treated with 
concentrations ranging from 100 nM to 50 µM 
(8 replicates for each). After 4 days of 
treatment, the cytotoxicity of each compound 
was measured by using the WST-1 kit (Roche). 
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